Glycosylation of immunoglobulin light chains associated with amyloidosis

Amyloid

Volumn 7, Issue 4, 2000, Pages 227-244

  Omtvedt, L A ^a   Bailey, D ^a   Renouf, D V ^a   Davies, M J ^a   Paramonov, N A ^a   Haavik, S ^a   Husby, G ^a   Sletten, K ^a   Hounsell, E F ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

AL amyloidosis; Amyloid fibrils; Bisected GlcNAc; Immunoglobulin; Light chain; Protein glycosylation

Indexed keywords

AMYLOID BETA PROTEIN; GLYCOPEPTIDE; IMMUNOGLOBULIN LIGHT CHAIN; MONOSACCHARIDE; OLIGOSACCHARIDE;

ALZHEIMER DISEASE; AMYLOIDOSIS; ARTICLE; CARBOHYDRATE ANALYSIS; GLYCOSYLATION; HUMAN; MATHEMATICAL MODEL; METHYLATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 0033635821     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506120009146437     Document Type: Article

References (64)

1. On the association between amyloid fibrils and glycosamanoglycans; possible interactive role of Ca2+ and amyloid P-component
2. From arthritis to Alzheamer's disease current concepts on the pathogenesis of amyloidosis
3. Advanced glycation end products contribute to amyloidosis in Alzheimer disease
4. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukln-1
5. Glycosylation of microtubule-associated protein tau an abnormal posttranslational modification in Alzheimer's disease
6. Blockade of glycosylation promotes acquisition of scrapie-like properties by the prion protein in cultured cells
7. Amyloid fibril proteins proof of homology with immunoglobulin light chains by sequence analyses
8. Treatment of amyloadosis
9. Tertiary structure of an amyloid immunoglobulin light chain protein: A proposed model for amyloid fibril formation
10. Molecular modeling of immunoglobulin light chains implicates hydrophobic residues m non-amyloid light chain deposition disease
11. Pathogenic potential of human monoclonal immunoglobulin light chains relationship of m vitro aggregation to in vivo organ deposition
12. Attachment of carbohydrate to the variable region of myeloma immunoglobulin light chains
13. Localization of the carbohydrate within the variable region of light and heavy chains of human gamma g myeloma proteins
14. Diversification of the IgG molecule by ollgosaccharades
15. Structural studles of the variable region of Ig light chain-type amyloid fibril proteins
16. Structures of the carbohydrate moieties of two monoclonal human lambda-type immunoglobulin light chains
17. The primary structure of a monoclonal human lambda-type immunoglobulin L-chain of subgroup II (Bence-Jones protein NEI)
18. Localization of the carbohydrate units in a human immunoglobulin light chain, protein Sm lambda
19. A monoclonal immunoglobulin G1 in which some molecules possess glycosylated light chains - I Site of glycosylation
20. Differential glycosylation of Bence Jones protein and kidney impairment in patients with plasma cell dyscrasia
21. Structure and role of oligosaccharides in antibody light chains and their modification with glycosylation-based cytotechnology
22. Human-human hybridomas secreting antibodies specific to human lung carcinoma
23. A molecular model for self-assembly of amyloid fibrils immunoglobulin light chains
24. A role for destabilizing amino acid replacements in light-chain amyloidosis
25. Specificity of abnormal assembly in immunoglobulin light chain deposition disease and amyloidosis
26. A chemical approach to elucidate the meachanism of transthyretin and b-protein amyloid fibril formation
27. The carbohydrate structure of the amyloid immunoglobulin light chain protein EPS
28. Conformational studies of the glycopeptide Ac-Tyr-[Man5GlcNAc(β1-4)GlcNAc(β1-N(δ))]-Asn-Leu-Thr-Ser-OBz and the constituent peptide and oligosaccharide
29. The amino acid sequence of the glycosylated amyloid immunoglobulin light chain protein AL MS
30. A glycosylated Bence Jones protein and its autologous amyloid light chain containing potentially amyloidogenic residues
31. Chemical characterization of high potential iron proteins from chromatium and rhodopseudomonas gelatinosa
32. The complete amino acid sequence of a prototype immunoglobulinlambda light-chain-type amyloid-fibril protein AR
33. Substrate specificity of a proteolytic enzyme isolated from a mutant of Pseudomonas fragi
34. Monosaccharide and oligosaccharade analysis of proteins transferred to polyvinylidene fluoride membranes after sodium dodecyl sulfate-polyacrylamide gel electrophoresis
35. A simple and rapid method for the permthylation of carbohydrate
36. Coherence transfer by isotropic mixing application to proton correlation spectroscopy
37. 1H-NMR spectra via two-dimensional homonuclear Hartmann-Hahn spectroscopy
38. MLEV-17 based two-dimensional homonuclear magnetization transfer spectroscopy
39. Multiple quantum filters for elucidating NMR coupling networks
40. Practical aspects of two-dimensional transverse NOE spectroscopy
41. Structure determination of a tetrasaccharide transient nuclear overhauser effects in the rotating frame
42. Multiple quantum filters for elucidating NMR coupling networks
43. Conformational studies of the backbone (poly-N-acetyllactosamane) and the core region sequences of O-linked carbohydrate chains
44. Accessing the Kabat antibody sequence database by computer Proteins Structure
45. Constant region of a kappa III immunoglobulin light chain as a major AL - amyloid protein
46. Structure of a novel Bence-Jones protein (Rhe) fragment at 1 6 A resolution
47. Conformational studies of the backbone (poly-N-acetyllactosamine) and the core region sequences of O-linked carbohydrate chains
48. PROMOTIF - A program to identify and analyze structural motifs in proteins
49. Isolation and characterization of glycoproteins
50. Comparison of the amino acid sequence often kappa I amyloid proteins for amyloidogenic sequences
51. Structural studies of two carbohydrate-containing AL chains (lambda II) AL NOV and AL MC
52. Characterization of a kappa AL protein and two amyloidogenic kappa BJP in three cases of immunoglobulin amyloidosis
53. Complementary DNA sequence of human amyloidogenic immunoglobulin lightchain precursors
54. Bioclonality in amyloidosis patient MAL one clone producing an amyloidogenic, the other a non-amyloidogenic kappa L-chain
55. Glycosylated immunoglobulin light chains associated with amyloidosis
56. High-resolution, 1H-nuclear magnetic resonance spectroscopy as a tool in the structural analysis of carbohydrates related to glycoproteins
57. The potency of amide protons for assignments of NMR spectra of carbohydrate chains of glycoproteins, recorded in 1H2O solutions
58. Structures of the carbohydrate moiety attached to one site in the first domain of turkey ovomucoid elucidation by proton-NMR
59. Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients
60. Glycobiology, 'the function of sugar in the IgG molecule'
61. 2O
62. Clinical implications of monoclonal light chains
63. Antibody variable region glycosylation position effects on antigen binding and carbohydrate structure
64. The amino-acid sequence of the variable region of a carbohydrate- containing amyloid fibril protein EPS (immunoglobulin light chain, type lambda)